Workflow
UREVO Announces Skiing Champion Brothers as Brand Ambassadors
Globenewswire· 2025-06-11 05:56
Core Insights - UREVO has appointed New Zealand freestyle skiers Luca and Ben Harrington as brand ambassadors to promote its smart fitness products, emphasizing athletic recovery and healthy living [1][9] Company Overview - UREVO is a global innovator in smart fitness technology, focusing on developing intelligent wellness solutions that support healthy and active lifestyles [10] Product Highlights - The UREVO CyberPad for Office Smart Treadmill features a dual brushless motor system with up to 2.5HP power and operates at a low noise level of 45dB, designed for both home and office use [5][6] - The CyberPad includes MegaLift incline technology with a gradient of up to 14%, a 6.4-inch slim profile, and a 100cm walking area, enhancing user comfort while working [5][6] - The UREVO AI-Powered Wireless Recovery Massager replicates physiotherapy treatments with an advanced Matrix Airbag Design targeting five compression zones, offering six massage modes and eight pressure levels [7][8] - The massager integrates with the UREVO App to provide personalized recovery recommendations based on muscle state assessment, with a battery life of up to 240 minutes [8] Market Trends - The partnership with the Harrington brothers reflects a broader trend of integrating digital tools with physical wellness practices, enhancing UREVO's global visibility [9]
NKT A/S concludes share buyback programme
Globenewswire· 2025-06-11 05:46
Core Viewpoint - NKT A/S has successfully concluded its share buyback programme initiated to fulfill obligations related to employee incentive programmes [1] Group 1: Share Buyback Programme Details - The share buyback programme was executed in compliance with European regulations, specifically Regulation No. 596/2014 and Commission Delegated Regulation (EU) 2016/1052 [2] - From 22 May 2025 to 10 June 2025, NKT A/S repurchased a total of 268,949 shares for a total expenditure of DKK 146.1 million (EUR 19.6 million) [2] - The average transaction prices for shares varied, with the highest being DKK 566.74 on 28 May 2025 and the lowest being DKK 519.09 on 22 May 2025 [3] Group 2: Transaction Breakdown - The number of shares bought back and corresponding amounts for specific trading days are as follows: - 22 May 2025: 37,000 shares for DKK 19,206,344.80 - 23 May 2025: 37,000 shares for DKK 19,725,791.50 - 26 May 2025: 28,613 shares for DKK 15,594,022.05 - 27 May 2025: 41,000 shares for DKK 23,157,673.30 - 28 May 2025: 36,387 shares for DKK 20,622,001.13 - 2 June 2025: 20,000 shares for DKK 11,114,314.00 - 3 June 2025: 20,000 shares for DKK 10,513,722.00 - 4 June 2025: 20,000 shares for DKK 10,516,644.00 - 6 June 2025: 20,000 shares for DKK 10,804,064.00 - 10 June 2025: 8,949 shares for DKK 4,850,923.58 [3] - Following the buyback, NKT A/S holds a total of 269,594 treasury shares, representing 0.50% of the total share capital [3]
AbbVie Inc. (ABBV) Presents at Goldman Sachs 46th Annual Global Healthcare Conference Transcript
Seeking Alpha· 2025-06-11 05:36
Core Insights - AbbVie is actively engaging with the administration regarding drug pricing policies and is optimistic about the productive nature of these discussions [3][4]. Group 1: Company Overview - AbbVie is represented by its entire management team at the Goldman Sachs 46th Annual Global Healthcare Conference [1]. - Robert A. Michael, CEO & Director, emphasizes the importance of addressing affordability and access to medicines while maintaining innovation [4]. Group 2: Industry Environment - The pharmaceutical sector is currently facing uncertainties related to drug pricing policies, particularly following the Most Favored Nation Executive Order [3]. - The administration's engagement with the pharmaceutical industry is seen as a positive development, indicating a willingness to discuss various topics related to drug pricing and access [4].
CROSSJECT advances on the development of ZEPIZURE® Junior, its solution for epilepsy crises in children
Globenewswire· 2025-06-11 05:30
Press release CROSSJECT advances on the development of ZEPIZURE® Junior, its solution for epilepsy crises in children Announces the effective calibration of ZENEO® for the use of ZEPIZURE® in the pediatric population.CROSSJECT completed an echography clinical study allowing to determine and validate the targeted depth of injection in children as compared to adults. Dijon, France 11 June 2025 (07h30 CET) -- CROSSJECT (ISIN: FR0011716265; Euronext: ALCJ), the specialty pharma company in advanced phases of dev ...
ONWARD Medical Schedules Webcast to Provide Q1 2025 Business Update and Year-To-Date Highlights
Globenewswire· 2025-06-11 05:30
EINDHOVEN, the Netherlands, June 11, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD and US OTCQX: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function and independence in people with spinal cord injury and other movement disabilities, today announces that it will host a webcast to discuss its Q1 2025 business update and year-to-date highlights. The webcast will be held on June 17, 2025, at 2:00PM CET / 08:00AM ET. It will be hosted by CEO Dave Marver. ...
Fnac Darty implements a share buyback program
Globenewswire· 2025-06-11 05:30
Ivry-sur-Seine, France, June 11, 2025 – 7:30AM Fnac Darty implements a share buyback program Fnac Darty has announced the implementation of a share buyback program for a total of 600,000 shares as part of the share buyback program authorised at the Shareholders’ Meeting of May 28, 2025. A first buyback mandate has been granted to investment services provider NATIXIS for a maximum amount of €5 million. This initiative follows on from the Board of Directors’ decision to allow share buyback in the proportion ...
Sanuwave: High Growth Wound Care Tech Primed For A Breakout
Seeking Alpha· 2025-06-11 05:13
Group 1 - The article discusses the experience of an investor who began trading during the pandemic and emphasizes the importance of analyzing earnings reports to identify potential growth stocks [1] - The investor successfully identified several future winners, including OPRX, OTRK, FUBO, and PLUG, by focusing on key information from earnings transcripts and reports [1]
Biotalys Reports Progress in the Regulatory Review of EVOCA in both US and EU
Globenewswire· 2025-06-11 05:00
US EPA projects taking a regulatory decision by end of September 2025; Dutch authorities finalise first phase of regulatory dossier for EVOCA in EuropeGhent, BELGIUM, June 11, 2025 (GLOBE NEWSWIRE) -- Press release Biotalys (Euronext - BTLS), an Agricultural Technology (AgTech) company developing protein-based biocontrols for sustainable crop protection, is pleased to announce progress in the regulatory approval procedures in both the United States and Europe of its first protein-based biocontrol product, E ...
Net Asset Value of EfTEN Real Estate Fund AS as of 31 May 2025
Globenewswire· 2025-06-11 05:00
In May, EfTEN Real Estate Fund AS earned consolidated rental income of EUR 2,643 thousand, increasing by EUR 33 thousand compared to April. The increase in rental income is  mainly related to the higher revenue in the logistics segment (including the first full month of rental income from the Paemurru logistics centre) and contract-based rent increases in the elderly care segment.The Fund’s consolidated EBITDA in May totalled EUR 2,229 thousand (April: EUR 2,183 thousand). Adjusted cash flow (EBITDA less lo ...
Coop Pank AS results for May 2025
Globenewswire· 2025-06-11 05:00
Coop Pank’s financial results in May 2025: In May, number of the bank's clients increased by 1,500 and number of active clients decreased by 800. By the end of the month number of clients reached 216,00 and number of active clients reached 102,400. Over the year, customer base has grown by 11%. Volume of the bank's customer deposits decreased by 47 million euros in May. The reduction in deposit volume was a deliberate step, as an additional 250 million euros was raised in March through the issuance of cover ...